Rituxan Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Condition:   Mantle Cell Lymphoma Interventions:   Drug: Zanubrutinib;   Biological: Rituximab;   Other: Patient Observation;   Procedure: Bone Marrow Biopsy;   Other: Fludeoxyglucose F-18;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Procedure: Magnetic Resonance Imaging;   Procedure:  Esophagogastroduodenoscopy;   Procedure: Colonoscopy;   Procedure: Biospecimen Collection;   Other: Questionnaire Administration Sponsors:   Alliance for Clinical Trials in Oncology;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2023 Category: Research Source Type: clinical trials